Peginesatide

Category: Anemia

Peginesatide Overview

Peginesatide[2] (INN/USAN, trade name Omontys, formerly Hematide), developed by Affymax and Takeda, is an erythropoietic agent, a functional analog of erythropoietin. It was approved by the U.S. Food and Drug Administration for treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis.[3][4] On February 23, 2013, Affymax and Takeda issued a press release indicating that they were recalling all batches of pegi...

Read more Peginesatide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Peginesatide

Recent Peginesatide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Peginesatide

Injection: 1mg/0.5ml, 2mg/0.5ml, 3mg/0.5ml, 4mg/0.5ml, 5mg/0.5ml, 6mg/0.5ml
Solution: 10mg/ml (10mg/ml), 1mg/0.5ml (1mg/0.5ml), 20mg/2ml (10mg/ml), 2mg/0.5ml (2mg/0.5ml), 3mg/0.5ml (3mg/0.5ml), 4mg/0.5ml (4mg/0.5ml), 5mg/0.5ml (5mg/0.5ml), 6mg/0.5ml (6mg/0.5ml)

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Peginesatide or a similar ingredient: (1 result)

OMONTYS Peginesatide